The disconnect between the primary policy assumption underpinning the HTA Review, which is that products must be found safe and effective to be funded, demonstrates the extent of this MSAC outcome as a dangerous outlier. …
The danger of this outlier is reflected in the disconnect with another policy process
October 18, 2024 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Eight women named finalists for 2026 Marie Krogh Young Women in Science Prize
September 17, 2026 - - Latest News -
Your success makes you a target and take it as a compliment
September 16, 2026 - -
From constitutional promise to creaking system - the PBS at 80
September 16, 2026 - - Latest News -
Young Australians badly misjudge when fertility starts to decline, new survey finds
September 16, 2026 - - Latest News -
New research points to a 'Doctor gap' holding back clinical trial participation in Australia
September 16, 2026 - - Latest News -
New Zealand ranks last among wealthy nations on modern medicines access, new report finds
September 16, 2026 - - Latest News -
A shorter name and bolder blue for Novo in global rebrand
September 15, 2026 - - Latest News